Join
Live feed
·
INSIDERFilingvia Quantisnow
Cartesian Therapeutics Inc. logo

Chief Technology Officer Kurtoglu Metin sold $81,790 worth of Common Stock (4,875 units at $16.78), decreasing direct ownership by 7% to 62,258 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RNAC· Cartesian Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RNAC (Cartesian Therapeutics Inc.) and more on Quantisnow.